TABLE 2

Decay-Corrected Percentage Uptake Value of Administered 188Re-HEDP in Whole Body, Skeleton, and Bone Metastases of 13 Patients

UptakeTime after administration
3 h*20 h*28 h*
Whole body (%)64.6 ± 20.549.3 ± 16.443.8 ± 15.2
Skeletal (%)50.9 ± 14.946.1 ± 14.839.9 ± 14.6
Bone metastases (%)1.51 ± 0.571.45 ± 0.681.42 ± 0.56
  • * Time after therapy.